More than 26,000 people in the U.S. will be diagnosed with stomach cancer this year, and nearly 11,000 people will die of the disease, according to the American Cancer Society. Stomach cancer accounts for about 1.5% of all ...
Feb 7, 2024
0
0
Imec teamed up with the KU Leuven laboratory of tumor immunology and immunotherapy for the first clinical validation of its cell sorter chip technology. The chip successfully identified PD-1 positive T cells in the blood ...
Feb 2, 2024
0
0
Real-time magnetic resonance (MR) imaging during gene therapy in the nervous system provides foundational impact on optimizing the effectiveness, safety and efficiency of gene therapy delivery to the nervous system.
Jan 29, 2024
0
51
A stem cell therapy for Crohn's disease developed by UC Davis Health researchers has shown promising results in mouse studies.
Jan 29, 2024
0
73
One of the great promises in the field of cancer immunotherapy is the emergence of cancer vaccines. Unlike traditional vaccines that are tailored to infectious diseases, cancer vaccines work by teaching the immune system ...
Jan 17, 2024
0
2
The face reflects a person's emotional state. The interpretation of facial expressions as part of psychotherapy or psychotherapeutic research, for example, is an effective way of characterizing how a person is feeling in ...
Dec 29, 2023
0
26
Liver cancer rates have more than tripled in the U.S. since 1980 and continue to rise. More than 41,000 people will be diagnosed with liver cancer in the U.S. this year, and about 29,000 will die from the disease, according ...
Dec 13, 2023
0
0
Patients undergoing total thyroidectomy typically require lifelong oral levothyroxine sodium (L-T4) treatment. While effective in maintaining basic serum hormone levels, this treatment falls short in restoring the dynamic, ...
Dec 12, 2023
0
33
Immunotherapy has been disappointing as a prostate cancer treatment, but a new Columbia study suggests that the powerful treatments have potential when the disease starts to spread.
Dec 12, 2023
0
47
Researchers from the Germans Trias i Pujol Research Institute (IGTP) have led a comprehensive review study on biomarkers for the often-overlooked partial remission phase of type 1 diabetes in collaboration with experts in ...
Nov 14, 2023
0
5
